Highlights of the Day: 2015 ASCO Annual Meeting
The 2015 ASCO Annual Meeting is the platform for the release of thousands of scientific abstracts -- highly anticipated cancer research news for many people, including patients, caregivers, and the public. ASCO is pleased to share this timely information with the public in a variety of ways. On this page, highlights of the scientific news program will be posted each day of the meeting from Friday, May 29 to Monday, June 1, 2015, so be sure to bookmark this page now!
If you would prefer to receive this information in an daily email during the Annual Meeting, sign up now to receive special editions of the free newsletter Inside Cancer.Net. You can also follow Cancer.Net on Twitter, Facebook or Google+, where real-time updates will be posted.
Monday, June 1, 2015
Thank you for using Cancer.Net as your resource for breaking news, research summaries, and expert discussions over the last four days of the 2015 ASCO Annual Meeting. In case you missed any of the research presented this weekend, you can find highlights of the latest advances from the 2015 ASCO Annual Meeting in this interactive PDF or on the Cancer.Net Blog.
Welcome to New Editor in Chief, Lidia Schapira, MD, FASCO
Cancer.Net is pleased to welcome Dr. Lidia Schapira in her new role as Editor in Chief, beginning today. Dr. Schapira is a medical oncologist at Massachusetts General Hospital Cancer Center and Associate Professor of Medicine at Harvard Medical School. She has served on the Cancer.Net Editorial Board as the Associate Editor of Psychosocial Oncology for more than 10 years.
Video Highlighting Research News
With Peter Paul Yu, MD, FACP, FASCO, ASCO President
In this video, Dr. Yu discusses the practice-changing research that came out of Sunday’s Plenary Session at the ASCO Annual Meeting, and what it means for people living with cancer.
Watch for the Research Round Up Podcasts This Summer
Throughout the summer, watch for the Cancer.Net Research Round Up podcast series that covers additional scientific findings from the 2015 ASCO Annual Meeting. Led by experts, these topic-specific podcasts are designed to help deepen your knowledge about the wave of cancer research released at this meeting.
Announcing The Campaign to Conquer Cancer
This week, the Conquer Cancer Foundation announced the launch of The Campaign to Conquer Cancer, a multi-year effort established to do one BIG thing: take down cancer. To do that, we need your help to spread the word. Learn more at conquer.org and participate on social media with #ConquerCancer.
Coming Soon! Cancer.Net Mobile Update
A companion to the Cancer.Net website, Cancer.Net Mobile (for Android and iOS) includes up-to-date guides on more than 120 types of cancer, with information about treating cancer, managing side effects, managing the cost of care, and living with cancer. Interactive tools allow you to keep track of questions to ask doctors and record voice answers; save information about prescribed medications; and track the time and severity of symptoms and side effects.
Keep an eye out for a newly optimized version of this mobile app, offering an all-new visual design as well as a personalized selector for your type of cancer, with real-time updates from the Cancer.Net website.
Sunday, May 31, 2015
New advances in cancer care and survivorship continue to come out of the 2015 ASCO Annual Meeting. Today’s Plenary Session features selected research that has the greatest potential to immediately affect the care of people with cancer, both within the United States and worldwide. These studies help answer long-standing questions about the optimum treatment across several types of cancer, weighing side effects against survival and risk of recurrence.
Plenary Session Research News
- Improved Care and Treatment Helps Children with Cancer Live Longer and Better
- The Side Effects of Whole Brain Radiation Therapy for Brain Metastases May Outweigh the Benefits for Some Patients
- Choosing Lymph Node Surgery Earlier May Be a Better Option for Some Patients with Oral Cancer
- Nivolumab Slows Melanoma Growth Better than just Ipilimumab
Podcast Highlighting Research News
With Jyoti D. Patel, MD
In this podcast, Dr. Patel discusses the new study released today about the timing of lymph node removal for early oral cancer, and what it means for people diagnosed with this type of cancer.
Videos Highlighting Research News
With Peter Paul Yu, MD, FACP, FASCO, ASCO President, and Julie M. Vose, MD, MBA, FASCO, ASCO President-Elect
In these two videos, ASCO leaders describe new studies from the ASCO Annual Meeting, and what it means for patients and caregivers. Watch Dr. Yu discuss rare and common cancers, and Dr. Vose discuss targeted therapies.
Cancer Survivorship Resources and Downloadable Guide
Today, people diagnosed with cancer are living longer and better lives than ever, thanks to improved treatments, screening, and means of managing side effects, but cancer survivors often have unique needs and medical concerns. Learn more about cancer survivorship, and find the downloadable ASCO Answers: Guide to Cancer Survivorship that helps people with cancer better understand survivorship, including its psychological, physical, sexual, reproductive, financial, and work-related challenges, with questions to ask the health care team, and a blank treatment and survivorship care plan.
Resources to Help You Quit Smoking
Today is World No-Tobacco Day! It is never too late to stop using tobacco products, and Cancer.Net offers a variety of resources to help you quit.
Saturday, May 30, 2015
The 2015 ASCO Annual Meeting is underway. You can continue to find breaking news about the research being presented on Cancer.Net and through Cancer.Net’s social media channels, including Facebook, Twitter, and Google+.
Today’s research highlights advances in targeted treatments for several hard-to-treat blood cancers and new treatment approaches for rare and common cancers.
New Research on Targeted Therapies
Until recently, cancer treatment was largely based on the location in the body where the tumor began, such as the lung or breast. However, targeted therapies rely on specific characteristics of a person’s tumor, such as gene mutations (changes) or specific proteins that are often characteristic of cancer cells, rather than the original location of the cancer. Learn more about targeted therapies.
The following studies explore advances in targeted therapies:
- Adding Ibrutinib to Standard Treatment Lowers the Risk of Dying from Chronic Lymphocytic Leukemia
- New Treatment, Pacritinib, Helps Ease Myelofibrosis Symptoms
- Obinutuzumab Controls Growth of Slow-Growing Non-Hodgkin Lymphoma
- Daratumumab May Be an Effective Treatment for Multiple Myeloma
Progress Against Rare & Common Cancers
Treatments for many types of cancer, both rare and common, are being studied in clinical trials across the world. Among the new research released today at the ASCO Annual Meeting were studies that focused on new or refined types of treatment for some of the most common cancers, while another study presents a new treatment for a rare form of sarcoma.
- Adding Chemotherapy Improves Survival for Men with High-Risk, Localized Prostate Cancer
- Some People with Melanoma May Not Need Extensive Lymph Node Surgery
- Eribulin Helps People with Two Rare Types of Soft-Tissue Sarcoma Live Longer
- Anastrazole Helps Reduce Breast Cancer Risk after DCIS for Postmenopausal Women
- New Targeted Drug Slows Growth and Spread of Metastatic Breast Cancer
Video Highlighting Research News
With Peter Paul Yu, MD, FACP, FASCO, President of ASCO
Watch as Dr. Yu discusses what the new immunotherapy research presented at the ASCO Annual Meeting means for people living with cancer.
Video-Based Education Program on Clinical Trials
The new research coming out of the ASCO Annual Meeting is a result of clinical trials, which are the main way that new medical approaches are tested to see how well they work. To help patients and their caregivers learn about clinical trials, Cancer.Net provides free access to PRE-ACT (Preparatory Education About Clinical Trials), a video-based educational program. You can choose to have PRE-ACT personalize the videos based on your answers to a short survey or simply browse the library of videos on more than 20 topics.
Learn more about PRE-ACT on the Cancer.Net Blog in this guest post by Neal Meropol, MD, FASCO, the co-creator of PRE-ACT.
Friday, May 29, 2015
Right now in Chicago, more than 30,000 cancer specialists from around the world are gathering to discuss the latest advances in cancer care, treatment, prevention, and survivorship at the 2015 ASCO Annual Meeting. Cancer.Net, ASCO's patient education website, is excited to provide you with the following summaries and discussions by ASCO experts about what these studies mean for patients, as well as their friends and families.
New Research on Immunotherapy
Immunotherapy is a type of cancer treatment designed to boost the body's natural defenses, or immune system, to treat cancer. Learn more about immunotherapy.
Earlier today, exciting new research about treatments that target the PD-1 protein was presented at the meeting. This class of drugs is being tested across several types of cancer. Use the links below to learn more about these studies:
- Genetic Changes May Help Predict Who Will Benefit Most from PD-1 Immunotherapy
- Nivolumab Shows Promise as a Treatment Option for Advanced Liver Cancer
- Early Research Shows Potential of Pembrolizumab as Head and Neck Cancer Treatment
- Nivolumab Extends the Lives of People with the Most Common Type of Lung Cancer
Immunotherapy in Lung Cancer
The field of immunotherapy is rapidly expanding, and nivolumab (Opdivo) is one of the promising new treatments being tested for several types of cancer. First approved for the treatment of melanoma, nivolumab was also recently approved by the U.S. Food and Drug Administration for the treatment of advanced squamous non-small cell lung cancer.
In this expert podcast, Julie Brahmer, MD, puts this development into perspective, sharing what it means for the treatment of lung cancer.
Follow #ASCO15 for Up-To-Date Information
Whether you are in Chicago or following the news from home, find up-to-date information by following @CancerDotNet on Twitter, liking Cancer.Net’s page on Facebook, or adding Cancer.Net to your circles on Google+. Cancer.Net provides a guide to this year’s Annual Meeting social media coverage, including how to get topic-specific coverage and follow ASCO’s expert tweeters.
And, if you are in Chicago and on Twitter, be sure to join the May 30 Tweet-up for #ASCO15. There’s still time to RSVP!